Endocyte Inc (ECYT) financial statements (2022 and earlier)

Company profile

Business Address 3000 KENT AVE STE A1-100
WEST LAFAYETTE, IN 47906
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments97,471138,207173,600125,070123,281175,838
Cash and cash equivalents18,55931,22815,43245,53352,84733,997
Short-term investments78,912106,979158,16979,53670,434141,841
Receivables2735597066,3535,689
Prepaid expense7511,7377736103,201
Prepaid expense and other current assets3,298
Other current assets77256494653496
Total current assets:98,573140,256174,876127,038133,332184,825
Noncurrent Assets
Property, plant and equipment2,1823,2053,3983,9713,8393,167
Long-term investments and receivables   81,76125,57225,541
Long-term investments   81,76125,57225,541
Other noncurrent assets73411231115
Prepaid expense and other noncurrent assets546
Total noncurrent assets:2,1893,2393,51085,76329,52629,254
TOTAL ASSETS:100,762143,494178,386212,801162,858214,079
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,9104,0875,3394,49510,1707,977
Accounts payable3761,3821,2631,2355,4353,648
Accrued liabilities  8046931,6691,903
Employee-related liabilities2,5332,7053,2722,5683,0662,427
Debt     13
Deferred revenue and credits   5059,74751,993
Other liabilities   318 
Other undisclosed current liabilities1,6371,4758502,3373,7282,487
Total current liabilities:4,5465,5626,1896,88573,66362,470
Noncurrent Liabilities
Long-term debt and lease obligation     42
Capital lease obligations     42
Liabilities, other than long-term debt73278585091296551,993
Deferred revenue and credits73278283288293251,993
Other liabilities 3193033 
Total noncurrent liabilities:73278585091296552,035
Total liabilities:5,2786,3477,0397,79774,629114,505
Stockholders' equity
Stockholders' equity attributable to parent95,484137,147171,346205,00488,22999,573
Common stock484242423636
Additional paid in capital404,455390,769381,118373,572262,061255,357
Accumulated other comprehensive income (loss)(64)(41)(79)(144)5773
Accumulated deficit(308,955)(253,623)(209,735)(168,465)(173,925)(155,892)
Total stockholders' equity:95,484137,147171,346205,00488,22999,573
TOTAL LIABILITIES AND EQUITY:100,762143,494178,386212,801162,858214,079

Income statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues70707070,35364,87134,682
Revenue, net  2052,72013,4207,220
Cost of revenue
(Cost of Goods and Services Sold)
    (51,600)(27,500)
Gross profit:70707070,35313,2717,182
Operating expenses(56,176)(44,790)(42,043)(65,327)(83,213)(50,725)
Other undisclosed operating income    51,60027,500
Operating income (loss):(56,106)(44,720)(41,973)5,027(18,342)(16,043)
Nonoperating income (expense)12(28)52435312(620)
Investment income, nonoperating   580466328
Other nonoperating income (expense)12(28)52(145)(154)(948)
Interest and debt expense   (1)(2)(1,621)
Income (loss) before gain (loss) on sale of properties:(56,094)(44,749)(41,921)5,461(18,032)(18,284)
Other undisclosed net income1,029     
Net income (loss):(55,064)(44,749)(41,921)5,461(18,032)(18,284)
Other undisclosed net income (loss) attributable to parent 861652(1) 992
Net income (loss) available to common stockholders, diluted:(55,064)(43,888)(41,270)5,459(18,032)(17,292)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(55,064)(44,749)(41,921)5,461(18,032)(18,284)
Other comprehensive income (loss)  65(201)(16) 
Comprehensive income (loss):(55,064)(44,749)(41,857)5,260(18,048)(18,284)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(23)899652(1) 1,071
Comprehensive income (loss), net of tax, attributable to parent:(55,087)(43,849)(41,205)5,259(18,048)(17,213)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: